Mangaluru-Mysuru road is too bad; introduce flight: S L Bhyrappa

Bengaluru, Mar 26: Karnataka Primary and Higher Education Minister Suresh Kumar on Thursday clarified that the SSLC examinations have not canceled as being claimed by many. 

Taking to Twitter, he said there was confusion among students and parents as wrong news was published in a some of the news papers and even in social media also.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Mangaluru/Udupi, Jun 7: Coastal districts of Dakshina Kannada and Udupi have recorded 17 and 13 new coronavirus positive cases between 5 p.m. on June 6 and 5 p.m. on June 7. 

16 among 17 new covid patients in Dakshina Kannada are returnees from Maharashtra, while one returned from Goa recently.

Maharashtra returnees comprise 14 males, including three teenagers t, and two females aged 32 and 41. The Goa returnee is a 32-year-old male.

All of them have all been admitted to the designated COVID hospital in the district.

With this, the total tally of coronavirus cases in Dakshina Kannada has risen to 203, out of which 47 are currently active. As many as 150 patients have recovered and been discharged, and seven have died.

Among the 13 in Udupi, 12 are Maharashtra returnees, while process of contact tracing of one patient, a 30-year-old woman, is going on.

The patients comprise eight males, including a 7-year-old boy, and five females. They have all been admitted to the designated hospital.

This takes the total number of coronavirus cases in Udupi district to 902, out of which 798 are currently active, 103 discharged, and one patient has died.